Imaging application of an MMP2-sensitive tumor-targeted prussian blue fluorescent nanoprobe

In recent years, the application of nanoimaging technology on standardize tumor diagnosis has become a new research hotspot, especially nanoprobes. Our research group has synthesized a kind of nanocarrier, mPEG2000-GPLGIAGQ-DSPE, which has the characteristic of matrix metalloproteinase-2 (MMP2) sensitive ability in tumor microenvironment. Meanwhile, the encapsulation method is adopted to prepare MMP2-sensitive tumor-targeted prussian blue fluorescent nanoprobe with mPEG2000-GPLGIAGQ-DSPE as the carrier. On the one hand, this novel nanoprobe not only can effectively improve the solubility of prussian blue, but is non-toxic and safe for cells. On the other hand, octapeptide (GPLGIAGQ) in mPEG2000-GPLGIAGQ-DSPE nanocarrier can specifically respond to MMP2 in tumor cells to release prussian blue, and achieve targeted intelligent imaging of tumor cells.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:38

Enthalten in:

Journal of biomaterials applications - 38(2023), 3 vom: 16. Sept., Seite 372-380

Sprache:

Englisch

Beteiligte Personen:

Zhou, Xinglu [VerfasserIn]
Zhang, Changmei [VerfasserIn]
Zhou, Qiquan [VerfasserIn]
Liang, Jian [VerfasserIn]
Zhang, Xiaoyan [VerfasserIn]
Shi, Yujie [VerfasserIn]
Zhu, Jingna [VerfasserIn]
Zhong, Lei [VerfasserIn]

Links:

Volltext

Themen:

EC 3.4.24.24
Ferric ferrocyanide
Ferrocyanides
Fluorescent nanoprobe
Imaging
Journal Article
MMP2
MMP2 protein, human
Matrix Metalloproteinase 2
Prussian blue
Research Support, Non-U.S. Gov't
TLE294X33A
Tumor

Anmerkungen:

Date Completed 12.09.2023

Date Revised 14.09.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1177/08853282231194147

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM360309445